Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Emeryville, CA
SEC filing record 1 source field available
Fiscal year end
31 December
4D Molecular Therapeutics, Inc. has filed 421 SEC EDGAR filings since 13 Aug 2015

SEC filing history

Showing 376-400 of 421 matching filings.

Per page
25
Current page
16
SC 13G File 005-91921

ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
21 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Dec 2020
Reporting date
15 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Dec 2020
Reporting date
15 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Dec 2020
Reporting date
15 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Dec 2020
Reporting date
15 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A

Filing date
17 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-251370

S-8

Filing date
15 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39782

8-K

Filing date
15 Dec 2020
Reporting date
15 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-250150

424B4

Filing date
14 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
11 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-250150

EFFECT filing

Filing date
10 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1MEF File 333-251277

S-1MEF

Filing date
10 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
10 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .